Aslıhan DOĞRU -TDO- The European Medicines Agency (EMA) has taken the vaccine developed by Chinese-based company Sinovac against the new type of coronavirus (Covid-19) into the preliminary evaluation process.
The Results of the CoronaVac vaccine for animal and human trials are being evaluated, the European Medicines Agency announced on May 4th.
Sinovac submitted data for vaccine tests to the European Medicines Agency.
It is also important for international travel that the vaccine is approved by Europe.
Vaccines developed by China and Russia have not yet received approval from the health authorities of the European Union (EU).